SCGB3A2 and pulmonary fibrosis: Histological examination revealed that both BLM-treated wild-type and Scgb3a2-transgenic mice developed extensive pulmonary fibrosis by 3 weeks based on a whole lung H&E stained images (Fig. 2b) and Masson Trichrome staining (Fig. 2c).